JP2009512699A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009512699A5 JP2009512699A5 JP2008536688A JP2008536688A JP2009512699A5 JP 2009512699 A5 JP2009512699 A5 JP 2009512699A5 JP 2008536688 A JP2008536688 A JP 2008536688A JP 2008536688 A JP2008536688 A JP 2008536688A JP 2009512699 A5 JP2009512699 A5 JP 2009512699A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- oral dosage
- concentration
- active substance
- drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/257,432 US20070092559A1 (en) | 2005-10-24 | 2005-10-24 | Liquid dosage forms having enteric properties of delayed and then sustained release |
| PCT/US2006/039761 WO2007050294A2 (en) | 2005-10-24 | 2006-10-11 | Liquid dosage forms having enteric properties of delayed and then sustained release |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009512699A JP2009512699A (ja) | 2009-03-26 |
| JP2009512699A5 true JP2009512699A5 (https=) | 2009-11-26 |
Family
ID=37744211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008536688A Pending JP2009512699A (ja) | 2005-10-24 | 2006-10-11 | 遅延放出とその後の持続放出の腸溶性を有する液体剤形 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20070092559A1 (https=) |
| EP (1) | EP1940365A2 (https=) |
| JP (1) | JP2009512699A (https=) |
| CN (1) | CN101296690A (https=) |
| WO (1) | WO2007050294A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| ES2360423T3 (es) | 2006-04-26 | 2011-06-03 | Supernus Pharmaceuticals, Inc. | Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal. |
| US20100099696A1 (en) * | 2008-10-16 | 2010-04-22 | Anthony Edward Soscia | Tamper resistant oral dosage forms containing an embolizing agent |
| US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US8895536B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating chronic inflammation and inflammatory diseases |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
| CN110314152B (zh) * | 2018-11-27 | 2021-03-26 | 西安圣雪沙药物开发有限公司 | 一种布洛芬缓释微丸胶囊及其制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL148500B (nl) * | 1967-10-07 | 1976-02-16 | Scherer Gmbh R P | Depotgeneesmiddelen in capsulevorm. |
| GB1322306A (en) * | 1971-04-15 | 1973-07-04 | Meiji Seika Co | Stabilized antibiotic preparation and manufacturing process therefor |
| US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| DE3500103C2 (de) * | 1985-01-04 | 1987-01-22 | R.P. Scherer GmbH, 6930 Eberbach | Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff |
| US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
| US4835186A (en) * | 1987-06-15 | 1989-05-30 | American Home Products Corporation | Spray dried ibuprofen |
| JPS649932A (en) * | 1987-07-01 | 1989-01-13 | Toyo Capsel Kk | Soft capsule preparation using newly combined component as the base |
| JPH082781B2 (ja) * | 1988-10-18 | 1996-01-17 | 嘉明 川島 | 中空顆粒状医薬及びその製法 |
| US5527545A (en) * | 1989-09-18 | 1996-06-18 | Recordati S.A. Chemical And Pharmaceutical Company | Liquid-suspension controlled-release pharmaceutical composition |
| IT1250654B (it) * | 1991-07-08 | 1995-04-21 | Farcon Ag | Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph. |
| US5723151A (en) * | 1995-11-06 | 1998-03-03 | Eastman Chemical Company | Cellulose acetate phthalate enteric coating compositions |
| CN1494920A (zh) * | 1996-06-19 | 2004-05-12 | ��˹��ŵ�� | 含有环孢菌素的软胶囊制剂 |
| PT1003476E (pt) * | 1997-08-11 | 2005-05-31 | Alza Corp | Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica |
| US6191162B1 (en) * | 1998-05-28 | 2001-02-20 | Medical Research Institute | Method of reducing serum glucose levels |
| US6312713B1 (en) * | 1998-06-12 | 2001-11-06 | Bernard Korol | Polymer matrices for storage and sustained release of drugs and chemicals |
| US6139875A (en) * | 1998-09-29 | 2000-10-31 | Eastman Chemical Company | Aqueous enteric coating composition and low gastric permeability enteric coating |
| US6174873B1 (en) * | 1998-11-04 | 2001-01-16 | Supergen, Inc. | Oral administration of adenosine analogs |
| WO2000035419A2 (en) * | 1998-12-17 | 2000-06-22 | Alza Corporation | Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| US6797283B1 (en) * | 1998-12-23 | 2004-09-28 | Alza Corporation | Gastric retention dosage form having multiple layers |
| US6635281B2 (en) * | 1998-12-23 | 2003-10-21 | Alza Corporation | Gastric retaining oral liquid dosage form |
| US6342249B1 (en) * | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
| JP4610687B2 (ja) * | 1999-11-15 | 2011-01-12 | コニカミノルタホールディングス株式会社 | 原稿読み取り装置 |
| US20040028744A1 (en) * | 2002-06-17 | 2004-02-12 | Sauwaluxana Tongaree | Mucoadhesive composition |
| EP1713454A4 (en) * | 2003-09-11 | 2008-07-02 | Glykon Technologies Group Llc | Enteric release of (-) - hydroxycitric acid |
| GB0403808D0 (en) * | 2004-02-20 | 2004-03-24 | Bioprogress Technology Ltd | Films for use as dosage forms |
-
2005
- 2005-10-24 US US11/257,432 patent/US20070092559A1/en not_active Abandoned
-
2006
- 2006-10-11 CN CNA2006800396750A patent/CN101296690A/zh active Pending
- 2006-10-11 EP EP06816742A patent/EP1940365A2/en not_active Withdrawn
- 2006-10-11 WO PCT/US2006/039761 patent/WO2007050294A2/en not_active Ceased
- 2006-10-11 JP JP2008536688A patent/JP2009512699A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009512699A5 (https=) | ||
| JP2012153724A5 (https=) | ||
| US11207273B2 (en) | Method of making an L-menthol dosage form | |
| CN1404389B (zh) | 时控脉冲给药系统 | |
| JP4172917B2 (ja) | 急速に効果を発揮し且つ効果的な血漿薬物濃度が急速に低下する制御放出性製剤 | |
| JP2020059755A5 (https=) | ||
| EP0825854B1 (en) | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery | |
| JP2017019858A5 (https=) | ||
| US20120244216A1 (en) | Coated pharmaceutical capsule dosage form | |
| JP2008540419A5 (https=) | ||
| JPH11505253A (ja) | 結腸デリバリー用の医薬投与形態 | |
| KR20100014629A (ko) | 타크로리무스의 변형제형 | |
| JP2005510539A (ja) | 複数のコーティングを有する医薬剤形 | |
| JP2012519725A (ja) | 治療薬の徐放性組成物 | |
| JP2009512699A (ja) | 遅延放出とその後の持続放出の腸溶性を有する液体剤形 | |
| CA2967647A1 (en) | Pharmaceutical bead formulations comprising dimethyl fumarate | |
| CN1341014A (zh) | 含氯雷他定和伪麻黄碱的药物胶囊组合物 | |
| EP0381220B1 (en) | Water dispersible gemfibrozil compositions | |
| CN103417544A (zh) | 甲氨叶酸复方制剂及其制备方法和用途 | |
| JP5443768B2 (ja) | 医薬品球状物 | |
| CN104274408A (zh) | 一种熔融包衣的速释药物微粒及其制备方法 | |
| WO1998022096A1 (en) | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery | |
| Bansal et al. | Delivery Strategies and Clinical Significance of Oral Colon-targeted Drug Delivery Systems | |
| CA2271560C (en) | Pharmaceutical dosage form for colonic delivery | |
| CN103211770A (zh) | 一种艾拉莫德缓释多元组合物及其制备方法 |